Literature DB >> 9780193

Weak anamnestic responses of inbred mice to Yersinia F1 genetic vaccine are overcome by boosting with F1 polypeptide while outbred mice remain nonresponsive.

P Brandler1, K U Saikh, D Heath, A Friedlander, R G Ulrich.   

Abstract

The role of immunity to intracellular Ags in resistance to infection by Yersinia is not well established. The enteropathogenic bacteria Yersinia pseudotuberculosis and Yersinia enterocolitica actively translocate Ags to the cytosol of eukaryotic cells. Whereas Yersinia pestis does not always express the requisite cellular adhesins, results have varied as to whether similar cytosolic translocation of Ags occurs in vitro. We used a genetic vaccine to induce intracellular expression of the fraction 1 (F1) capsular protein of Y. pestis within host mammalian cells and examined the ensuing immune response. The F1 genetic vaccine stimulated only weak CTL responses in BALB/c mice. Substantial Ab responses to the F1 genetic vaccine were obtained in all inbred strains of mice tested, but Ab levels were less than those resulting from vaccination with the F1 polypeptide. In contrast, outbred mice did not respond to the F1 plasmid, suggesting that some inbred mouse strains may exhibit exaggerated responses to plasmid vaccines. A primary immunization with the F1 genetic vaccine followed by a boost with recombinant F1 polypeptide produced a vigorous Ab response from inbred mice that was equivalent to three injections of F1 polypeptide. We conclude that cytosolic expression of the F1 Ag efficiently primes immunity, while secondary exposure to the F1 polypeptide is required for optimal Ab induction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9780193

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague.

Authors:  Hitoki Yamanaka; Teri Hoyt; Xinghong Yang; Sarah Golden; Catharine M Bosio; Kathryn Crist; Todd Becker; Massimo Maddaloni; David W Pascual
Journal:  Infect Immun       Date:  2008-08-11       Impact factor: 3.441

2.  An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague.

Authors:  Hitoki Yamanaka; Teri Hoyt; Richard Bowen; Xinghong Yang; Kathryn Crist; Sarah Golden; Massimo Maddaloni; David W Pascual
Journal:  Vaccine       Date:  2008-10-26       Impact factor: 3.641

3.  Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen.

Authors:  Haim Grosfeld; Sara Cohen; Tamar Bino; Yehuda Flashner; Raphael Ber; Emanuelle Mamroud; Chanoch Kronman; Avigdor Shafferman; Baruch Velan
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

4.  Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.

Authors:  Alexandra J Spencer; Matthew G Cottingham; Jennifer A Jenks; Rhea J Longley; Stefania Capone; Stefano Colloca; Antonella Folgori; Riccardo Cortese; Alfredo Nicosia; Migena Bregu; Adrian V S Hill
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.